|Susann J. Jarhult, MD, PhD||Massachusetts General Hospital, Department of Emergency Medicine, Boston, Massachusetts;
Uppsala University, Department of Medical Sciences, Uppsala, Sweden
|Melissa L. Howell, BA, BS||Massachusetts General Hospital, Department of Emergency Medicine, Boston, Massachusetts|
|Isabelle Barnaure-Nachbar, MD||Geneva University Hospitals, Department of Radiology, Geneva, Switzerland|
|Yuchiao Chang, PhD||Massachusetts General Hospital, Department of Medicine, Boston, Massachusetts|
|Benjamin A. White, MD||Massachusetts General Hospital, Department of Emergency Medicine, Boston, Massachusetts|
|Mary Amatangelo, RN||Brigham and Women’s Hospital, Department of Neurology, Boston, Massachusetts|
|David F. Brown, MD||Massachusetts General Hospital, Department of Emergency Medicine, Boston, Massachusetts|
|Aneesh B. Singhal, MD||Massachusetts General Hospital, Department of Neurology, Boston, Massachusetts|
|Lee H. Schwamm, MD||Massachusetts General Hospital, Department of Neurology, Boston, Massachusetts|
|Scott B. Silverman, MD||Massachusetts General Hospital, Department of Neurology, Boston, Massachusetts|
|Joshua N. Goldstein, MD, PhD||Massachusetts General Hospital, Department of Emergency Medicine, Boston, Massachusetts|
Our goal was to assess whether use of a standardized clinical protocol improves efficiency for patients who present to the emergency department (ED) with symptoms of transient ischemic attack (TIA).
We performed a structured, retrospective, cohort study at a large, urban, tertiary care academic center. In July 2012 this hospital implemented a standardized protocol for patients with suspected TIA. The protocol selected high-risk patients for admission and low/intermediate-risk patients to an ED observation unit for workup. Recommended workup included brain imaging, vascular imaging, cardiac monitoring, and observation. Patients were included if clinical providers determined the need for workup for TIA. We included consecutive patients presenting during a six-month period prior to protocol implementation, and those presenting between 6–12 months after implementation. Outcomes included ED length of stay (LOS), hospital LOS, use of neuroimaging, and 90-day risk of stroke or TIA.
From 01/2012 to 06/2012, 130 patients were evaluated for TIA symptoms in the ED, and from 01/2013 to 06/2013, 150 patients. The final diagnosis was TIA or stroke in 45% before vs. 41% after (p=0.18). Following the intervention, the inpatient admission rate decreased from 62% to 24% (p<0.001), median ED LOS decreased by 1.2 hours (5.7 to 4.9 hours, p=0.027), and median total hospital LOS from 29.4 hours to 23.1 hours (p=0.019). The proportion of patients receiving head computed tomography (CT) went from 68% to 58% (p=0.087); brain magnetic resonance (MR) imaging from 83% to 88%, (p=0.44) neck CT angiography from 32% to 22% (p=0.039); and neck MR angiography from 61% to 72% (p=0.046). Ninety-day stroke or recurrent TIA among those with final diagnosis of TIA was 3% for both periods.
Implementation of a TIA protocol significantly reduced ED LOS and total hospital LOS.
Transient ischemic attack (TIA) affects 0.3% of the United States population annually and is associated with high risk for stroke or cerebrovascular accident. 1-3 The risk of subsequent ischemic stroke is up to 5% in the first 48 hours, and up to 12% within the first 30 days. 4-7
Data has shown that urgent workup and treatment can minimize this risk. 5, 6, 8-10 Therefore, the early stages of TIA represent a tremendous opportunity for stroke prevention. Many TIA patients present to, or are referred to, the emergency department (ED), and for many healthcare systems the ED represents both the point of first healthcare contact and location for initial workup. However, it is unclear if the emergent workup is best performed in the ED, inpatient unit, or on an outpatient basis. 11-13 Some healthcare systems have developed rapid TIA outpatient clinics, 14-17 but these are not widely available in the U.S. As a result, many patients in U.S. systems receive inpatient hospitalization, and recent study results point to a significant increase in admit rates for TIA. 18, 19
In our hospital we noted substantial variability in workup, both in types of testing and in ED and in-patient length of stay (LOS). In addition, it appeared that there were opportunities to streamline care and improve our ability to risk-stratify patients. Therefore, to optimize quality and efficiency, in 2012 we developed a protocol-based pathway for acute TIA management (Figure). This pathway was based upon existing guidelines including those from the American Heart Association 20 (AHA) (published in 2009). These highlighted the value of clinical information in risk stratification; brain imaging (including magnetic resonance imaging), and cerebrovascular imaging. In particular, they included recommendations regarding the use of the ABCD2 score for risk stratification; therefore, these were included in our pathway.
Finally, other studies had suggested that an ED observation unit (EDOU) may provide an optimized pathway for TIA evaluation, and so we incorporated its use for selected patients. 17, 21, 22 While less common in other countries, EDOUs are increasingly used in the U.S. for patients who require more than a brief ED stay but less than 24 hours of observation or urgent diagnostics. 23 Our EDOU was managed by a nurse practitioner (NP) who was empowered to guide patients who would likely require more than 24 hours for their workup, based on availability of hospital resources at the time. In this analysis, we evaluated whether we could use this pathway to provide consistent streamlined care with shorter LOS without increasing 90-day stroke risk.
We performed a retrospective cohort analysis of patients presenting during the six-month time period before protocol implementation (see Figure for protocol), and then the same six-month time period the following year (six months after protocol implementation). The research protocol was approved by the institutional review board (IRB).
Population Health Research Capsule
What do we already know about this issue?
Patients with transient ischemic attack (TIA) are often admitted. Some studies have suggested that ED observation units can provide appropriate care more efficiently.
What was the research question?
What would be the impact on patients’ length of stay and outcomes if we were to implement a TIA protocol incorporating an ED observation unit?
What was the major finding of the study?
Our protocol provided the same high-quality care with reduced length of stay, and no increased risk.
How does this improve population health?
TIA protocols using ED observation units can provide safe and efficient care, returning patients home more quickly, and freeing hospital capacity for patients with greater inpatient needs.
This study took place at a large, urban, tertiary, academic hospital with approximately 1,000 inpatient beds and approximately 100,000 ED visits per year.
Patients with suspected TIA were eligible if they presented to our ED (either primarily or in transfer) and if clinical providers determined that a TIA workup was necessary. To capture all eligible patients, we used a number of overlapping methods. First, we queried a hospital-based centralized electronic data registry using the following ICD-9 codes between January 1, 2011, and December 31,2013: Intracranial Hemorrhage (ICH): 430–432.9; Acute Ischemic Stroke 434.91; and Transient Ischemic Attack (TIA) 435.9. We included the diagnosis of ICH to capture the possibility that some patients may have presented with TIA symptoms but were ultimately diagnosed with ICH. Second, we queried our hospital’s ongoing AHA Get-With-The-Guidelines® data collection, a prospectively collected cohort of all patients with stroke or TIA. 24 Third, we queried our ED electronic record for all patients with chief complaint or final diagnosis that included the term “TIA.” Fourth, we queried our ED electronic record for all patients receiving neurology consultation. Most of the patients captured by this criterion did not actually present with TIA (as they included all neurology consultations), but this method provided a wide net (maximal sensitivity) for all those presenting with TIA symptoms, even if the workup ultimately yielded an alternate diagnosis (such as brain tumor or intracerebral hemorrhage).
A physician then reviewed each medical record to determine whether patients truly had TIA symptoms and whether symptoms had resolved at the time of evaluation. We included patients if clinical providers evaluated and worked up the patient for TIA. For patients with multiple visits, we collected data on the first visit only, and recorded the following visits as adverse events if within the given timeframe of data collection.
We performed a structured chart review, collecting data on patient demographics, imaging, workup, ED LOS, and hospital LOS. Two physicians abstracted data. Demographics collected included age, sex, presenting features, and past medical history. We calculated the primary outcome LOS, based on times of registration and transfer – all abstracted electronically; therefore, no inter-rater agreement was calculated. Imaging data included all brain and vascular imaging. Data were collected on workup including any echocardiography or Holter monitoring. We captured final diagnoses of the clinical providers (after the ED workup). Neuroimaging was reviewed for clinically relevant findings (such as ischemic stroke, carotid artery stenosis, tumor, etc). In addition, the physician reviewer independently determined a likely final diagnosis. To evaluate outcome and adverse events, we reviewed the electronic record for followup outpatient visits and inpatient visits, up to 90 days after initial presentation. This electronic record review included data from our hospital as well as six other local hospitals covered by the same IRB.
We performed statistical analysis using SAS version 9.4 (SAS Institute, Cary NC). Continuous variables were summarized using median with inter-quartiles and compared using Wilcoxon rank-sum tests. We summarized categorical data using frequency and percentage and compared them using Fisher’s exact tests. A two-sided p-value 0.05 or less was considered statistically significant.
Our search strategy yielded 3,388 visits, of which 989 (29%) were overlapping. After removing these and repeat visits, 2,399 unique visits remained, of which 1,043 occurred during the time period of analysis. After chart review, 280 patients were found to have presented with transient neurologic symptoms that received evaluation for TIA; 130 patients were worked up for TIA before and 150 after protocol implementation. Table 1 shows the demographics of these two cohorts.
|Variable||Pre-intervention; n= 130||Post-intervention; n= 150||P value|
|Age, years; median (IQR)||70 (58–79)||68 (52–79)||0.16|
|Sex, Male (%)||67 (52)||73 (49)||0.72|
|Diabetes (%)||29 (22)||20 (13)||0.059|
|Initial SBP, mmHg Median (IQR)||152 (134–172)||150 (129–172)||0.54|
|Initial DBP, mmHg Median (IQR)||81 (71–90)||80 (70–90)||0.81|
To determine whether our intervention was associated with any changes in processes of care, we examined admission patterns, workup, and outcomes (Table 2). We found that patients admitted to ED observation increased from 27% to 72% (p<0.001). This was associated with a decrease in inpatient admissions from 62% to 24% (p<0.001). Median total hospital LOS (including time in ED, observation, and inpatient) also decreased from 29.4 (interquartile ration [IQR] 18.1–54.8) hours to 23.1 (IQR 15.9–35.7) hours (p=0.019).
|Pre-intervention; n= 130||Post-intervention; n= 150||P value|
|Discharged home from ED (%)||15 (11)||5 (3)|
|Admit ED obs (%)||35 (27)||108 (72)|
|Admit inpatient (%)||80 (62)||36 (24)|
|Head CT (%)||88 (68)||87 (58)||0.087|
|Neck CTA (%)||41 (32)||33 (22)||0.039|
|Brain MRI (%)||108 (83)||132 (88)||0.44|
|Neck MRA (%)||79 (61)||108 (72)||0.046|
|Carotid US (%)||14 (11)||15 (10)||0.99|
|Echocardiography (%)||50 (38)||52 (35)||0.36|
|Holter monitor while admitted||39 (30)||38 (25)||0.015|
|Holter planned after discharge||9 (7)||20 (13)||0.42|
|Length of stay|
|ED LOS in hours; median (IQR)||5.7 (4.0–7.8)||4.9 (3.5–6.4)||0.027|
|ED OBS LOS in hours, of those admitted to obs; median (IQR)||10.7 (6.0–17.3) N=46||15.6 (8.8–20.5) N=124||0.034|
|Inpatient LOS in hours, of those admitted; median (IQR)||39.1 (20.3–84.3) N=84||61.8 (39.4–98.2) N=37||0.057|
|Total Hospital LOS in hours; median (IQR)||29.4 (18.1–54.8)||23.1 (15.9–35.7)||0.019|
|Final diagnosis (%)||0.18|
|TIA||59 (45)||61 (41)|
|Stroke||19 (15)||15 (10)|
|ICH||0 (0)||0 (0)|
|Migraine||6 (5)||4 (3)|
|Infection||0 (0)||0 (0)|
|Tumor||0 (0)||3 (2)|
ED, emergency department; OBS, observation unit; CT, computed tomography, CTA, computed tomography angiography; MRI, magnetic resonance imaging; MRA, magnetic resonance angiography; US, ultrasound; LOS, length of stay; IQR, interquartile range; ICH, intracranial hemorrhage.
To examine whether there was a change in type of patients chosen for TIA workup (for example, providers increasing sensitivity by including lower probability TIA patients for workup), we examined the frequency with which final diagnosis was in fact TIA. We found that the distribution of final diagnosis was quite similar (p=0.19) with 45% TIA diagnosis before and 41% after. Of those ultimately found not to have a TIA, similar frequencies of alternative diagnoses were found (Table 2).
We noted that the majority of patients, both pre and post intervention, received brain imaging (99%) and vascular imaging (92%). For brain imaging, 52% of patients received both head computed tomography (CT) and brain magnetic resonance imaging (MRI), while only 4% received both CT angiography (CTA) and MR angiography (MRA). As our observation protocol included preferential use of MRI over CT, we examined whether head CT use changed. Use of head CT decreased from 68% to 58% (p=0.11) and from 32% to 22% (p=0.078) for neck CTA. Yield of various modalities (frequency with which a clinically-relevant, positive finding was diagnosed) is shown in Table 3. Significant findings on head CT were typically findings suggestive of recent infarction. Significant findings on CTA and MRA were typically findings of vascular stenosis or occlusions.
|Imaging modality||Pre-intervention||Post-intervention||P value|
|Head CT positive||3/89 (3%)||4/89 (4%)||0.99|
|Brain MRI positive||33/109 (30%)||29/131 (22%)||0.18|
|Neck CTA positive||21/40 (53%)||10/33 (30%)||0.063|
|Neck MRA positive||12/79 (15%)||6/108 (6%)||0.042|
|Carotid US positive||7/15 (47%)||5/15 (33%)||0.71|
CT, computed tomography, CTA, computed tomography angiography; MRI, magnetic resonance imaging; MRA, magnetic resonance angiography; US, ultrasound.
To examine whether our intervention, and its associated shorter LOS, led to higher risk of adverse outcomes, we evaluated risk of TIA or stroke within 90 days of presentation. Table 4 shows that short-term stroke and recurrent TIA rates were approximately 3% both pre and post intervention.
|Variable||Pre-intervention; n= 59||Post-intervention; n= 61||P value|
|Followup at our hospital outpatient neuro clinic (%)||25 (42)||31 (51)||0.37|
|Recurrent TIA within 90 days (%)||2 (3)||0 (0)||0.24|
|Stroke within 90 days (%)||0 (0)||2 (3)||0.50|
Overall we found that implementation of a TIA clinical pathway, incorporating the use of an ED observation unit for selected patients, shortened hospital LOS, and we found no evidence for increased risk of followup stroke.
After this study was completed, the American College of Emergency Physicians (ACEP) published guidelines for TIA management. 25 These guidelines suggested not using the ABCD2 score to determine which patients could be discharged from the ED before a complete workup, instead highlighting the value of urgent imaging. As the American Heart Association suggests, there is substantial value in using a tissue-based definition of TIA rather than time-based, a definition requiring brain imaging to evaluate for signs of areas of infarct. 20 In addition, many authors have found that clinical prediction scores that do not use imaging (such as the ABCD2 scores) do not appear adequately sensitive to safely guide which patients can be discharged prior to urgent evaluation. 26
We note that we did not (either before or after implementation of our clinical pathway) use the ABCD2 or another clinical score to discharge patients prior to urgent workup. Instead, our clinical pathway used this score to stratify which patients could receive their workup in an EDOU rather than as an inpatient. In fact, the ACEP guidelines included many elements that we had already included, such as “when feasible, physicians should obtain MRI with diffusion-weighted imaging (DWI) to identify patients at high short-term risk for stroke;” “When feasible, physicians should obtain cervical vascular imaging to identify patients at high short-term risk for stroke;” and “a rapid ED-based diagnostic protocol may be used to evaluate patients at short-term risk for stroke,” 25 As a result, our clinical pathway, although designed before these guidelines were published, remains concordant with them and remains in place today. It is also concordant with many suggested pathways in the literature. 26
Many centers have studied the optimal location for TIA workup. These have included outpatient TIA clinics where assessment, workup, diagnosis and treatment can be efficiently performed. These may reduce unnecessary or avoidable hospital admissions. 14, 27 Such clinics may be less common in the U.S. than in countries with single-payer healthcare systems. Others have studied the use of EDOUs, typically structured as an ED or inpatient unit but designed for patients who need more than an initial ED workup, but less than 24 hours of observation or evaluation. These can be lower cost (to the healthcare system) than an inpatient admission, and are increasing in popularity in the U.S. 23 Some have found that these EDOUs can minimize inpatient admission for lower risk TIA patients in a safe manner. 19, 22 Our results are consistent with these findings. It appears that urgent workup of low- and intermediate-risk patients can be safely performed in an EDOU, reserving high-acuity, in-hospital beds for just the highest risk patients or those with clinically significant findings on workup. Such efforts successfully reduced not just hospital admissions, but total hospital LOS for all patients, while ensuring all necessary workup was performed in the acute setting.
One common limitation in TIA studies is that they often include only those patients with final diagnosis of TIA. However, many patients present with symptoms concerning for TIA, who are later determined to have an alternate diagnosis. The strength of this study is that we included all patients for whom ED providers suspected TIA. However, as a result only about half of patients finally did have TIA, similar to other findings. 28, 29 One interesting finding was that while use of head CT was reduced, approximately half of patients still received one. Many patients received brain imaging with both CT and MRI, which may expose patients to avoidable radiation risk, as CT did not appear to offer additional information beyond what MRI could provide. It may be that providers wished to obtain head CT to screen for an emergent process before initiating the observation protocol and awaiting MRI (which takes much longer).
Our study had a number of limitations. First, it was limited to a single center, and our care pathways may not be the same as at other centers. Second, observational studies comparing before/after change implementation run the risk of other changes in clinical care happening at the same time. However, we are not aware of any changes in national or local recommendations for TIA workup during the time frame of this study. Third, adjudication of which patients truly had a TIA can be subject to inter-rater variability, which has been shown to be significant in several other studies. 30, 31 Fourth, as this was a retrospective study, our followup was limited to hospital records at our hospital and six other affiliates. We may have missed that some patients developed adverse events that were managed at other hospitals, or doctor offices. Fifth, we were unable to evaluate changes in cost, as cost data is typically not publicly available at our center.
In conclusion, we found that implementation of an ED observation-based TIA pathway led to shorter length of stay, with no evidence for increased risk of follow-up stroke.
Section Editor: William Whetstone, MD
Full text available through open access at http://escholarship.org/uc/uciem_westjem
Address for Correspondence: Joshua N. Goldstein, MD, PhD, Massachusetts General Hospital, Zero Emerson Place, Suite 3B, Boston, MA 02114. Email: firstname.lastname@example.org. 3 / 2018; 19:216 – 223
Submission history: Revision received June 16, 2017; Submitted September 11, 2017; Accepted September 18, 2017
Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. No author has professional or financial relationships with any companies that are relevant to this study. Dr. Goldstein has received research grants (to his institution) from Boehringer Ingelheim, Portola, and Pfizer. For the remaining authors no conflicts are declared. There was no funding for this research.
1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29-322.
2. Fuentes B, Gallego J, Gil-Nunez A, Morales A, Purroy F, Roquer J, et al. Guidelines for the preventive treatment of ischaemic stroke and tia (ii). Recommendations according to aetiological sub-type. Neurologia. 2014;29(3):168-83.
3. Murphy SL, Xu J, Kochanek KD. Deaths: Final data for 2010. Natl Vital Stat Rep. 2013;61(4):1-117.
4. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6(12):1063-72.
5. Johnston SC, Gress DR, Browner WS, et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284(22):2901-6.
6. Lovett JK, Rothwell PM. Site of carotid plaque ulceration in relation to direction of blood flow: an angiographic and pathological study. Cerebrovasc Dis. 2003;16(4):369-75.
7. Rothwell PM, Warlow CP. Timing of TIAs preceding stroke: time window for prevention is very short. Neurology. 2005;64(5):817-20.
8. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283-92.
9. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160-236.
10. Talwalkar A, Uddin S. Trends in emergency department visits for ischemic stroke and transient ischemic attack: United States, 2001–2011. NCHS Data Brief. 2015(194):1-8.
11. Lindley RI. Patients with transient ischemic attack do not need to be admitted to hospital for urgent evaluation and treatment: Against. Stroke. 2006;37:1139-40.
12. Luengo-Fernandez R, Gray AM, Rothwell PM. Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (express study): a prospective population-based sequential comparison. Lancet Neurol. 2009;8(3):235-43.
13. Siket MS, Edlow J. Transient ischemic attack: an evidence-based update. Emerg Med Pract. 2013;15(1):1-26.
14. Horer S, Schulte-Altedorneburg G, Haberl RL. Management of patients with transient ischemic attack is safe in an outpatient clinic based on rapid diagnosis and risk stratification. Cerebrovasc Dis. 2011;32(5):504-10.
15. Joshi JK, Ouyang B, Prabhakaran S. Should TIA patients be hospitalized or referred to a same-day clinic?: A decision analysis. Neurology. 2011;77(24):2082-8.
16. Lavallee PC, Meseguer E, Abboud H, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): Feasibility and effects. Lancet Neurol. 2007;6(11):953-60.
17. Merwick A, Kelly PJ. Transient ischaemic attack clinics and management of transient ischaemic attacks. Curr Opin Neurol. 2011;24(1):50-8.
18. Durrani-Tariq S, Eskin B, Allegra JR. Admission rates of ED patients with transient ischemic attack have increased since 2000. Am J Emerg Med. 2013;31(9):1349-51.
19. Stead LG, Bellolio MF, Suravaram S, et al. Evaluation of transient ischemic attack in an emergency department observation unit. Neurocrit Care. 2009;10(2):204-8.
20. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association stroke council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40(6):2276-93.
21. Nahab F, Leach G, Kingston C, et al. Impact of an emergency department observation unit transient ischemic attack protocol on length of stay and cost. J Stroke Cerebrovasc Dis. 2012;21(8):673-8.
22. Ross MA, Compton S, Medado P, et al. An emergency department diagnostic protocol for patients with transient ischemic attack: A randomized controlled trial. Ann Emerg Med. 2007;50(2):109-19.
23. Capp R, Sun B, Boatright D, et al. The impact of emergency department observation units on United States emergency department admission rates. J Hosp Med. 2015;10(11):738-42.
24. Ekundayo OJ, Saver JL, Fonarow GC, et al. Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get with the Guidelines-stroke. Circ Cardiovasc Qual Outcomes. 2013;6(3):262-9.
25. Lo BM, Carpenter CR, Hatten BW, et al. Clinical policy: critical issues in the evaluation of adult patients with suspected transient ischemic attack in the emergency department. Ann Emerg Med. 2016;68(3):354-70.e29.
26. Long B, Koyfman A. Best clinical practice: Controversies in transient ischemic attack evaluation and disposition in the emergency department. J Emerg Med. 2017;52(3):299-310.
27. Birns J, Vilasuso M, Cohen DL. One-stop clinics are more effective than neurology clinics for TIA. Age Ageing. 2006;35(3):306-8.
28. Schrock JW, Glasenapp M, Victor A, et al. Variables associated with discordance between emergency physician and neurologist diagnoses of transient ischemic attacks in the emergency department. Ann Emerg Med. 2012;59(1):19-26.
29. Ghia D, Thomas PR, Cordato DJ, et al. Validation of emergency and final diagnosis coding in transient ischemic attack: South western sydney transient ischemic attack study. Neuroepidemiology. 2010;35(1):53-8.
30. Castle J, Mlynash M, Lee K, et al. Agreement regarding diagnosis of transient ischemic attack fairly low among stroke-trained neurologists. Stroke. 2010;41(7):1367-70.
31. Ishida K, Raser-Schramm JM, Wilson CA, et al. Convergent validity and interrater reliability of estimating the ABCD2 score from medical records. Stroke. 2013;44(3):803-5.